Emr – Shaping The Future Of Healthcare

We all are aware of how the CMS multimillion dollar plan for EMR adoption created waves in the Healthcare IT industry. EMR was a proven tool to optimize practice operations and workflows. Large hospital corporations and technology enthusiasts were already reaping its benefits long before the government’s incentive program. Within the last two and a half years, EMR has managed to change the face of the Healthcare industry in the US. The adoption rates are now higher than ever. With the introduction of affordable, web-based EMR solutions, smaller practices can now look to automate their clinical and administrative processes as well.

While a practice may benefit from cost savings and improved productivity, the real benefactors are the patients themselves. An EMR offers increased quality of care through built-in interaction checks, improved accountability and ease of access, thus the future of healthcare backed by EMRs looks very promising indeed.
With increased focus on EDI and security, it is easier to anticipate what may come next. Healthcare portals are slowly gaining popularity amongst patients. With access to electronic personal health record, a patient is remains informed. The CMS wants to establish a new, more efficient method for care delivery by promoting online healthcare information exchange. This is also keenly reflected within the meaningful use objectives for stage 1 and the proposed stage 2.

Utilizing the technology available today, physician-patient interaction can be transformed completely. Integrated EMR Portals remove care delivery barriers and keep patients synchronized with real-time data to manage their health better. These may include online follow ups along with clinical alerts and reminders through instant messaging (email and text). With patients already using a patient portal to book their appointments, access lab results, request prescription refills and review visit notes, the next step may be a completely virtual clinical checkup.

With the development in online healthcare information exchange, patients can manage their health better and transport vital health information anywhere, anytime. EMR is definitely changing the healthcare system and a lot of us are just beginning to realize its significance, with the dawn of a new era of accountable and accessible care for all.

Indian Spices May Help Cure Cancer

According to Indian origin doctors based in US, kitchen spices such as turmeric, garlic, ginger, saffron, and capsicum known for their culinary versatility could be a powerful weapon to fight certain pathogens that can cause cancer.

Dr Shrikant Anant of the University of Kansas Medical Centre, US stated, Over the last 10 years, almost every academic institution and industrial group in the United States has started researching on the cancer-fighting properties of natural substances. Primarily, Indian-American doctors are involved in this, followed by Chinese and Koreans.”

Anti-cancer properties of curcumin and saffron
Laboratory research on animals suggests that curcumin (a derivative of the spice turmeric) has potent anticancer properties.

Now, researchers have launched the first phase of human trials to find out just how powerful it may be.

The researchers are also conducting experiments to determine whether the natural spices are effective in inhibiting cancerous tumors in isolation or when combined with existing therapy.

Lead researcher Dr Shrikanth Anant, professor of cancer research, University of Kansas stated, “Cancer is a complex disease. No therapy is a silver bullet. It has to be a combination. So, we’re looking at options that can make treatment more effective.

Meanwhile, Dr Animesh Dhar, associate professor in gastroenterology at the University of Kansas Medical Centre, is testing saffron for pancreatic cancer.

The studies on rodents revealed that orally administered crocetin, a natural carotenoid dicarboxylic acid found in saffron, appeared not only to slow the progression of the disease but also decreased the size of the tumor by half.

Dr Animesh Dhar stated, Crocetin a compound found in saffron, which has cancer-fighting properties was extensively used in ancient Chinese and Egyptian medicine.

Explaining further, he added, Our experiments on small animals have shown that Crocetin prevents proliferation of cancer cells. We are waiting for permission from the government to carry out clinical trials.

A herbal potion BIRM for prostate cancer
In addition, Addanki P Kumar of University of Texas Health Science Centre and Dr Bal Lokeshwar from the University of Miami have claimed success in reducing prostate cancer tumors by using a herbal potion extracted from the roots of Bryophyllum, known as BIRM.

Lokeshwar stated, We conducted an experiment by injecting mice with cancerous cells and treated a few of them with BIRM for 28 days, while others were left untreated. In mice treated with BIRM, the size of the tumour reduced from 100 units to 50, while in the untreated, the tumour grew from 100 to 250 units.

Online Pharmacy Offers Convenience in Buying Medicine, Get One Now at Online Pharmacy.

Affordable and convenient. If things like these are your basis of purchase, consider buying from online pharmacy like OnlinesPharmacy.com.

OnlinesPharmacy.com is the convenient and affordable alternative to conventional pharmacies. OnlinesPharmacy.com was formed with a dedication to providing consumers of all ages and lifestyles with assistance in better managing their own health care.

Just like the local pharmacy, OnlinesPharmacy.com has a wide variety of medicines, only online. They offer great discount prices on all our generic and brand name, each available to you with no prior prescription. OnlinesPharmacy.com is the place to get quality medical care without the trouble and time constraints of visiting a medical doctor or clinic. No Foreign Pharmacies! All medications are the same FDA approved medications available at your local pharmacy.

No prescription yet? OnlinesPharmacy.com provides free prescription with every order. They have 99% approval rate in every order! OnlinesPharmacy.com utilizes a team of licensed US doctors and pharmacies to issue you a free prescription and discreet overnight shipping from one of a licensed US located pharmacies. With a free prescription service in every order and overnight shipping, your order will arrive at your doorstep the very next day.

In a traditional pharmacy, some medicines can be purchased over-the-counter and some not, requiring prescription. But in OnlinesPharmacy.com, all medicines are available even without prior prescription. Such service is ideal to those with transportation issues and privacy needs because all medicines ordered from online pharmacy is delivered directly to you.

OnlinesPharmacy.com services include: US Licensed Pharmacies, US Licensed Doctors, Fed Ex Shipping, Free Medical Consultation and Free Prescription from US licensed doctors, Next Day Shipping, Saturday Shipping, Private & Confidential Service, Secure Online Order Form, $0 Medical Consultation Fee, No Prior Prescription Required, No Embarrassment. The range of services would also include necessary guidance by a medical practitioner provided through telephone or online.

All these and more! What else can you ask for? So for affordable and convenience, buy from online pharmacy like OnlinesPharmacy.com.

Gastric Cancer – Global Drug Forecasts And Treatment Analysis To 2020 Volume I 2011

GlobalData analysis finds that the global gastric cancer therapeutics market is attractive, and is primarily driven by the growth in the number of patients receiving gastric cancer therapy and the annual cost of therapy. The patient volume is primarily driven by an increase in patient volume in countries such as China, France, Spain and Italy. The patient volume was driven by growth in treatment usage patterns such as diseased population, treatment seeking population, diagnosis population and prescription population. The annual cost of gastric cancer therapy was driven by the launch of new therapies such as Taxotere (docetaxel), Xeloda (capecitabine) and Herceptin (trastuzumab).

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Gastric-Cancer-Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-Volume-1-2011&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

There is no standard care for gastric cancer. The treatment of gastric cancer is largely based on the treatment guidelines of different countries. Very few drugs are actually approved for gastric cancer, although many drugs are recommended for use
in treatment. Taxotere is approved as a first line therapy in gastric cancer. The introduction of new therapies for metastatic gastric cancer is expected to expand the market further.

In 2010, Japan was the leading market in the global gastric cancer therapeutics market with an estimated market share of approximately 24.7%. China was the second leading market with 17% market share. The US is the third largest gastric cancer market with a 15% market share. Japan and China lead the market due to a large patient base.

In 2010, Taxotere was the leading drug with approximate sales worth $170m and a market share of 30%. Herceptin, which was launched in the US and EU in 2010, is expected to gain market share in the forecast period 2010-2020.

GlobalData, the industry analysis specialist, has released its new report, Gastric Cancer – Global Drug Forecasts and Treatment Analysis to 2020 Volume I 2011. The report is an essential source of information and analysis on the global gastric cancer therapeutics market. The report provides comprehensive information on gastric cancer, highlighting the treatment guidelines. It identifies and analyses the key trends shaping and driving the global gastric cancer therapeutics market. It analyses the treatment usage patterns in the global gastric cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. The report provides valuable insights into the pipeline products within the global gastric cancer sector. It quantifies the unmet need in the global gastric cancer therapeutics market as well as in the individual markets such as the US and the top five countries in Europe, highlighting the opportunity for future players

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Gastric-Cancer-Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-Volume-1-2011&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.globaldata.com

For more details contact:
[emailprotected]
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782